共 101 条
- [1] Foo KT(2019)What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)? World J Urol 37 1293-1296
- [2] Cao Y(2016)A randomized, open-label, comparative study of efficacy and safety of tolterodine combined with tamsulosin or doxazosin in patients with benign prostatic hyperplasia Med Sci Monit 22 1895-338
- [3] Wang Y(2013)Comparative dissolution studies of an extended release Formulation of Tolterodine Tartrate and Tamsulosin HCl BioMedRx 1 333-S1867
- [4] Guo L(2013)Various analytical methodologies for determination of selective α1A receptor blocker tamsulosin hydrochloride and its combinations in different matrices World J Anal Chem 1 55006092-779
- [5] Yang X(2017)Simultaneous estimation of dutasteride and tamsulosin hydrochloride in tablet dosage form by vierordt’s method Arab J Chem 10 S1862-862
- [6] Chen T(2018)Enhanced spectrofluorimetric determination of two novel combination therapies for the treatment of benign prostatic hyperplasia containing tamsulosin hydrochloride Luminescence 33 771-29
- [7] Niu H(2016)Stability indicating HPLC method for quantification of solifenacin succinate & tamsulosin hydrochloride along with its impurities in tablet dosage form Am J Anal Chem 7 840-37
- [8] Mhamunkar S(2017)Superparamagnetic graphene oxide-based dispersive-solid phase extraction for preconcentration and determination of tamsulosin hydrochloride in human plasma by high-performance liquid chromatography–ultraviolet detection J Chromatogr A 1499 21-295
- [9] Mhamunkar SM(2019)Simultaneous HPLC determination of alfuzosin, tamsulosin and vardenafil in human plasma and pharmaceutical formulations using time programmed fluorescence detection Ann Pharm Fr 77 28-101
- [10] Srinivasan G(2021)Eco-friendly RP-HPLC and HPTLC methods for simultaneous determination of tamsulosin hydrochloride and deflazacort in the presence of 21-hydroxy deflazacort and testing the in-vitro dissolution of the combined dosage form via RP-HPLC method Chromatographia 84 285-101